Data backs Boston Scientific Sentinel cerebral protection system

Boston Scientific announced that its PROTECTED TAVR clinical trial evaluating its Sentinel system missed its primary endpoint.

Related Keywords

Boston ,Massachusetts ,United States ,United Kingdom ,Ian Meredith ,Samir Kapadia ,Marie Thibault ,Vascular Thoracic Institute ,Boston Scientific ,Suzanne Tomsich Department Of Cardiovascular Medicine ,Massachusetts Based Boston Scientific ,Transcatheter Cardiovascular Therapeutics ,New England Journal ,Suzanne Tomsich Department ,Cardiovascular Medicine ,Arnold Miller Family Heart ,Thoracic Institute ,